RPT-HeartWare device had 9.2% thrombosis rate in trial

(Repeating item that initially moved on Saturday) * Blood-clotting rate more than 9 pct per patient year * Higher than doctors or Wall Street expected * Rate could slow enrollment in clinical trial By Toni Clarke BOSTON/CHICAGO, April 16 (Reuters) -...